• Glumetinib Side Effects

  Glumetinib, a MET inhibitor, is primarily indicated for the treatment of advanced non-small cell lung cancer (NSCLC) harboring MET gene abnormalities.···【Read More】

  Update: 2026-01-26Source: Haiou HealthViews: 75

• Dosage and Administration of Gumetinib

  Gumetinib is an oral small-molecule MET inhibitor, primarily indicated for the treatment of adult patients with locally advanced or metastatic non-sma···【Read More】

  Update: 2026-01-26Source: Haiou HealthViews: 82

• Gumitinib Package Insert

  Savolitinib is a protein kinase inhibitor. It exerts dual therapeutic effects by precisely inhibiting the activity of c-Met protein kinase, a key &quo···【Read More】

  Update: 2026-01-26Source: Haiou HealthViews: 77

• Important Information for the Use of Savolitinib

  Savolitinib is a selective MET inhibitor, primarily indicated for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) h···【Read More】

  Update: 2026-01-23Source: Haiou HealthViews: 84

• Side Effects of Savolitinib

  Savolitinib is a targeted therapy agent indicated for specific malignancies. Common side effects include nausea, edema, abnormal liver and renal funct···【Read More】

  Update: 2026-01-23Source: Haiou HealthViews: 80

• Dosage and Administration of Savolitinib

  The standard administration of Savolitinib is oral. The recommended dose is 300 mg once daily, to be taken on an empty stomach (1 hour before meals or···【Read More】

  Update: 2026-01-23Source: Haiou HealthViews: 75

• Savolitinib Package Insert

  Savolitinib is a targeted therapy for specific types of lung cancer, primarily indicated for patients with advanced non-small cell lung cancer (NSCLC)···【Read More】

  Update: 2026-01-22Source: Haiou HealthViews: 78

• Contraindications of Orelabrutinib Tablets

  Orelabrutinib Tablets are a protein kinase inhibitor, indicated for the treatment of adult patients with mantle cell lymphoma who have received at lea···【Read More】

  Update: 2026-01-21Source: Haiou HealthViews: 76

• Precautions for Taking Orelabrutinib

  Orelabrutinib must be administered in strict compliance with the doctor’s instructions, with special attention paid to contraindications, dosage adjus···【Read More】

  Update: 2026-01-21Source: Haiou HealthViews: 76

• Adverse Reactions of Orelabrutinib

  As a medication indicated for the treatment of specific lymphomas, orelabrutinib may be associated with a spectrum of adverse reactions while deliveri···【Read More】

  Update: 2026-01-21Source: Haiou HealthViews: 78

• How Many Tablets of Orelabrutinib Should Be Taken Per Day?

  The daily dosage of orelabrutinib shall be determined based on the patient’s disease condition, physical status, and the physician’s instructions. Und···【Read More】

  Update: 2026-01-21Source: Haiou HealthViews: 77

• Instruction for Obutinib Tablets

  Orelabrutinib Tablets are an oral small-molecule targeted drug primarily indicated for the treatment of certain types of B-cell lymphoma. It exerts it···【Read More】

  Update: 2026-01-21Source: Haiou HealthViews: 76

• What is the Dosage of Lietinib?

  Reviewed by 3 experts including Wang Ruiqing from Beijing Tiantan Hospital, Capital Medical UniversityThe recommended standard dosage of Lietinib is 1···【Read More】

  Update: 2026-01-20Source: Haiou HealthViews: 79

• Liertinib Tablets

  Liertinib Tablets (trade name: Aoyixin) is an oral targeted anticancer drug indicated primarily for the treatment of adult patients with advanced non-···【Read More】

  Update: 2026-01-20Source: Haiou HealthViews: 79

• Important Usage Instructions for Olverembatinib

  Olverembatinib is a targeted therapy indicated for the treatment of specific types of leukemia. It is primarily prescribed for patients with chronic m···【Read More】

  Update: 2026-01-19Source: Haiou HealthViews: 82